What is the Canadian Technology Accelerator?

The Canadian Technology Accelerator (CTA) initiative was developed to provide Canadian companies with access to in-market entrepreneurial resources and contacts that can help them grow and compete internationally. It is managed by the Consulate General of Canada with close partnership with the CENE.

The CTA experience is a four month residency for one to two executives from a Canadian company. It is ideal for small, fast growing companies interested in establishing a presence in the market, pursuing venture capital, seeking strategic partnerships or acquiring new customers/clients. While at the CTA, companies are immersed in an entrepreneurial ecosystem that helps generate rapid growth and new ideas. Participants benefit from a culture of collaboration, open innovation and entrepreneurial inspiration cultivated among companies in the accelerator and surrounding ecosystem.

Why CTA@Boston?

The CTA@Boston, officially launched in March 2013, offers a vibrant collaborative work space and acceleration services for up to three months to Canadian companies seeking to engage in the New England ecosystem. Companies are guaranteed a seat at one of the CTA’s open work tables which can be accessed at their convenience. 

The CTA@Boston is housed at the Cambridge Innovation Center (CIC), conveniently located by the MIT campus in Kendall Square. This area features a number of leading venture capital firms, as well as the highest concentrations of life sciences and technology companies in the world: including, Google, Amazon, Biogen Idec, and Pfizer. Currently, more than 500 technology businesses benefit from CIC’s flexible office space and innovative business services.

How does the CENE help companies at the CTA@Boston?

CENE members leverage their collective experience, expertise and relationships to mentor CTA participants and connect them into the Boston ecosystem. Recognizing the current challenges in the Canadian venture capital industry, the CENE aims to harness the energy and expertise of a professional network of accomplished Canadian expatriates in the U.S. These individuals share a passion for their Canadian heritage and a desire to give back to Canada.

Visit the Canadian Trade Commissioner Service website for more details.


Interested in applying?

Contact Susan at the Canadian Consulate General in Boston



Immune Biosolutions

Immune Biosolutions is an innovative, environmentally and socially aware chicken antibody producer, focused on creating the best polyclonal and recombinant chicken antibodies as research and diagnostic tools, nutraceuticals and antibody-based drugs to explore and resolve important worldwide health issues.

Riipen Networks


Riipen is an experiential learning platform solution that connects top post-secondary students and recent graduates to employers through open challenges and in-class faculty-supervised industry projects. Students gain validated industry experience and incentives, organizations leverage student talent recruitment and cost-effective labor, and institutions increase experiential learning and in-class industry engagement for their students.



RocketRez provides fast, efficient ticket and retail sales in a unified Point-of-Sale. We dramatically increase our client's bottom line by providing real-time sales metrics in a very easy to use package. Integrated with a wide variety of hardware, from card readers to cash drawers and printers, RocketRez makes it easy to migrate; using existing hardware or upgrading to shiny new devices. RocketRez is a modern web-based, enterprise-tested platform that is currently in use by some of the largest tour operators in North America.

SPLICE Software


SPLICE works with Insurers – and their preferred vendors – to distribute personalized, interactive, real-time notifications to proactively notify both policy holders and applicable vendors of potential issues measured by smart home sensors.



VastCon's lead technology is simple, low cost, sensitive and specific blood test for early detection of colorectal cancer. Our test can be performed in any clinical or diagnostic laboratory. The technology, based on a patent pending discovery of biomarkers that are exclusively overexpressed in the peripheral blood of CRC patients, has the potential to replace the current fecal occult blood test (FOBT), a $ 6 billion market per year in North America and Europe alone.

The Rounds


The Rounds is a physician-only online professional network that doctors use at the point of care to deliver better outcomes.

Get on the List

Sign up to hear about all things CENE.​


Email Us
  • Twitter Social Icon
  • LinkedIn Social Icon
© 2020 Canadian Entrepreneurs in New England - 50 Milk Street - Boston, MA 02109